Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Buccal mucosa and gingivobuccal cancer (oral cancer in India), drawn from the whole corpus: 6 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Late presentation and rising incidence as areca nut and gutka use spread.
Nothing recorded yet.
Also on OnCo: Symptoms and red flags · Early detection roadmap.
Access to pembrolizumab, cetuximab and radiotherapy machines outside big cities.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Financial help · Coverage by country · HTA decisions.
Whether low-dose immunotherapy matches full-dose treatment.
Trismus and eating after cheek and jaw resection.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 14 changes by month →When this page itself was last checked or edited.
Median OS 10 vs 5 months, HR 0.
A milestone in how this cancer is treated.
Three-year disease-free survival 63.
1-year OS 43.
A milestone in how this cancer is treated.